Epidermal Growth Factor Receptor (HER1) Tyrosine Kinase Inhibitor ZD1839 (Iressa) Inhibits HER2/neu (erbB2)-overexpressing Breast Cancer Cells in Vitro and in Vivo1
Cancer Res (2001) 61 (24): 8887–8895.
Currently there are no citedby results. Try again later.
